Viatris sells off consumer, women’s health drugs in asset sales
Bio Pharma Dive
OCTOBER 2, 2023
The divestments will bring in more than $3 billion as the company works to reduce its debt and plan for future business development.
Hasten Biopharmaceutic raises $315m for pipeline assets development
Pharmaceutical Technology
APRIL 20, 2023
Chinese firm Hasten Biopharmaceutic has raised $315m for business development of its pipeline assets in a financing round co-led by Singapore-based CBC Group and Abu Dhabi sovereign wealth fund Mubadala Investment, The funding round was supported by additional institutional investors.
Development 
246
246 Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
BMS reports 2% revenue loss in 2023 after Revlimid generics hurt sales
Pharmaceutical Technology
FEBRUARY 2, 2024
Bristol Myers Squibb has reported a 2% revenue decrease from 2022 as it focuses on business development to counteract patent losses.
Sales 130
130 
Merck looks at M&A deals as COVID hits sales in Q1
pharmaphorum
APRIL 30, 2021
Pharmaceutical sales were flat on the same period of 2020 at $10.7 billion, with vaccines sales falling nearly 19% to $1.8 “We intend to use that capital both for business development and potentially share repurchase, but our clear priority is business development,” said Davis on the Q1 call.
Sales 90
90 
Blueprint Medicines announces financing partnerships for $1.25bn
Pharmaceutical Technology
JULY 1, 2022
The funding will offer capital to extend Blueprint’s varied pipeline toward marketing as well as to continue seeking strategic and synergistic business development prospects. The partnership with Royalty Pharma monetises royalty payments obtainable from net sales of Gavreto by Roche outside of the US, excluding Greater China.
Medicine 147
147 
Mainz Biomed Appoints Steve Quinn as VP Business Development
BioTech 365
JANUARY 27, 2022
Mainz Biomed Appoints Steve Quinn as VP Business Development Mainz Biomed Appoints Steve Quinn as VP Business Development Highly experienced diagnostics business development executive appointed to lead growth initiatives across international markets and drive international sales of ColoAlert at-home screening … Continue reading →
Aqilion and Merck partner to develop TAK1 protein inhibitors
Pharmaceutical Technology
FEBRUARY 16, 2023
Under the deal, Aqilion will receive $10.6m (€10m) in upfront cash payment from Merck and also eligible for up to $1,015m (€950m) in potential development and commercialisation milestone payments, along with tiered royalties on global net sales.
Protein 147
147 
The future's bright for Vetter - from lessons during the pandemic to a brand new facility
BioPharma Reporter
NOVEMBER 21, 2023
OSP was delighted to talk to Vetterâs Carsten Press, a senior leader of the global sales organization, and business development among many operational functions.
Branding 84
84 
CAPAssurance, a Risk Purchasing Group, Names Mitch Temple as Vice President Business Development
BioTech 365
JULY 19, 2021
CAPAssurance, a Risk Purchasing Group, Names Mitch Temple as Vice President Business Development CAPAssurance, a Risk Purchasing Group, Names Mitch Temple as Vice President Business Development Cooperative of American Physicians, Inc.
PharmaJet Announces Addition of Melissa Malhame as VP Business Development
BioTech 365
SEPTEMBER 29, 2020
Brings extensive experience in vaccine development and sales to the leadership team GOLDEN, Colo.–(BUSINESS –(BUSINESS WIRE)–PharmaJet®, the maker of innovative, needle-free injection technology, today announced that Melissa Malhame, has joined the leadership team as Vice President, Business Development.
eClinical Provider Crucial Data Solutions Appoints Brian Dufresne as SVP Business Development
Crucial Data Soutions
JUNE 27, 2022
Reno, NV, June 27, 2022 — Crucial Data Solutions (CDS), a provider of innovative low-code/no-code technologies to advance clinical research, announced today that industry veteran Brian Dufrense has joined the company as Senior Vice President, Business Development. Brian Dufresne, B.S.,
Business Development Is For Everyone In Clinical Research! Pharmacist Turned Entrepreneur Explains!
Clinical Trial Gurus
OCTOBER 5, 2021
Oftentimes as clinical research professionals we do not think of ourselves as sales people but expanding your opportunities in the life sciences industry is as important as anything else we will ever do for our careers.
Zerion and Insud to develop Dispersome formulations of drugs
Pharmaceutical Technology
AUGUST 30, 2022
Under the deal, Zerion will handle the development of Dispersome formulations of marketed drugs. The finished product dosage form, clinical development and the final products’ marketing and sales across the globe will be handled by Insud. . All the clinical and other development expenses will be handled by Insud.
Development 130
130 
Innate Pharma and Takeda sign licence deal to develop ADCs for coeliac disease
Pharmaceutical Technology
APRIL 3, 2023
The firm is also entitled to receive up to $410m for future development and regulatory and commercial milestones, provided these are attained within the timeline of the deal. In addition, Innate will receive royalties on possible net sales of any commercial product to be developed under the licence.
Development 130
130 
Christina Lake Cannabis Adds Sales and Business Development Leadership to its Roster
BioTech 365
OCTOBER 6, 2020
VANCOUVER, British Columbia, Oct. 06, 2020 (GLOBE NEWSWIRE) — Christina Lake Cannabis Corp.
Christina Lake Cannabis Adds Sales and Business Development Leadership to its Roster
BioTech 365
OCTOBER 6, 2020
VANCOUVER, British Columbia, Oct. 06, 2020 (GLOBE NEWSWIRE) — Christina Lake Cannabis Corp.
Leading pharmaceutical wholesalers
Pharmaceutical Technology
SEPTEMBER 5, 2022
Quality in terms of number of defective items, packaging and labelling, quality management system certification, research, development, and innovation. Services, such as customer relationship management (CRM), and after-sales service. Geographical location for timely delivery.
Packaging 130
130 
Why pharma isn’t yet achieving digital excellence, and how it can get there
pharmaphorum
MARCH 9, 2021
Nearly 70% of HCPs are now digital natives, with no interest in going back to pre-COVID sales engagement methods. Pre-COVID, digital sales engagement was mainly about emails – both reps-triggered emails that tended to be more personal and email campaigns prepared by HQ teams. Market pressures. Achieving digital excellence.
Sales 131
131 Leading clinical dose companies in contract marketing
Pharmaceutical Technology
SEPTEMBER 14, 2022
Contract marketing companies build a strong sales and marketing team rapidly and save efforts and time on the recruitment process. The download contains detailed information on the providers and their services and solutions, alongside contact details to aid your purchasing or hiring decision.
Marketing 100
100 
Pfizer vaults into sickle cell market as GBT deal confirmed
pharmaphorum
AUGUST 8, 2022
As we reported this morning, the deal gives Pfizer already-approved SCD therapy Oxbryta (voxelator) – which industry watchers reckon could see a dramatic uptick in sales with Pfizer’s marketing muscle – plus a phase 3 antibody candidate, a phase 1 follow-up to Oxbryta that could offer improved dosing. per-share deal valuing GBT at $5.4
Marketing 111
111 
Leading API chemical companies in contract marketing
Pharmaceutical Technology
SEPTEMBER 15, 2022
The document contains detailed information on the suppliers and their products, alongside contact details to aid your purchasing or hiring decisions.
Marketing 100
100 
Neurocrine Bio agrees $57m takeover of UK biotech Diurnal
pharmaphorum
AUGUST 30, 2022
In July, Diurnal reported product sales of around £2.3 The Cardiff-based company’s pipeline also includes an oral testosterone in clinical trials for hypogonadism, as well as a modified-release levothyroxine for hypothyroidism and oligonucleotide-based therapy for Cushing’s disease in preclinical development.
Hormones 105
105 
Merck confirms $11.5bn Acceleron takeover deal
pharmaphorum
SEPTEMBER 30, 2021
Merck said the two drugs will “complement and strengthen” its cardiovascular pipeline – which has been somewhat eclipsed by its vaccines and oncology businesses in recent years. Sales of Reblozyl were $240 million in the first half of the year, as booked by BMS, with Acceleron claiming a $48 million share of the total.
Sales 117
117 
Novartis will shed 7% of workforce in restructuring, say reports
pharmaphorum
JUNE 29, 2022
A decision on retaining, selling or spinning out Sandoz – which has been suffering from pressure on sales and operating profits in the last few years – is however not expected until the last quarter of this year.
Sales 98
98 
Leading commercial dose companies in contract marketing
Pharmaceutical Technology
SEPTEMBER 14, 2022
Commercial dose companies in contract marketing help in strategically positioning the products in the market, enabling patients to reap maximum benefit from it and transforming its sales management strategies. Discover the leading commercial dose companies in contract marketing.
Marketing 100
100 
Ferrer signs licence deal with Asceneuron for ASN90 to treat PSP
Pharmaceutical Technology
FEBRUARY 22, 2023
The deal terms include an upfront fee along with several development, regulatory, and commercial milestone payments. Additionally, Asceneuron is eligible for tiered double-digit royalties on ASN90’s global net sales.
Licensing 130
130 
CAMP4’s funding influx paves the way for tapping regulatory RNA to treat urea cycle disorders
Pharmaceutical Technology
JULY 29, 2022
A nitrogen-binding drug, its global sales were $292m in 2021, as per GlobalData. In order to achieve these plans, CAMP 4’s CEO, Josh Mandel-Brehm stated the company will prioritise raising capital through partnerships and business development. Other treatments include sodium phenylbutyrate marketed as Buphenyl or Ammonaps.
RNA 245
245 
Novartis decides Sandoz’ future – and it’s a spin-out
pharmaphorum
AUGUST 25, 2022
Novartis started a review of the business in October 2021, after Sandoz had been suffering from pressure on sales and operating profits for several years due mainly to pricing pressures, which were then compounded by the pandemic. Since then, the unit has seen something of a financial recovery, with first half 2022 sales up 6% to $4.68
Sales 105
105 
Adding value through coaching
pharmaphorum
MAY 17, 2022
Field forces are being realigned, business development re-focussed and digital channels maximised in a new era of sales and engagement. Coaching is now playing a pivotal role in driving better practice and sales performance and it is having an added benefit of boosting employee satisfaction, according to experts.
Sales 72
72 
Leading direct-to-consumer marketing companies for pharmaceuticals
Pharmaceutical Technology
SEPTEMBER 5, 2022
The information contained within the download document is designed for pharmaceutical executives, marketing managers, product managers, sales and marketing executives, medical representatives, software engineers, developers, business development executives and any other individual involved in the direct-to-consumer pharmaceutical marketing industry.
Marketing 130
130 
Leading freeze-drying systems suppliers for the pharmaceutical industry
Pharmaceutical Technology
MARCH 10, 2023
The list also includes manufacturers and suppliers of biological safety cabinets, clean benches, nanotechnology enclosures, drying chambers, vacuum pumps, filters, remote blowers and exhausters, loading and unloading systems as well as controlling and monitoring systems.
Manufacturing 147
147 
The future's bright for Vetter - from lessons during the pandemic to maintaining a happy team
BioPharma Reporter
NOVEMBER 21, 2023
OSP was delighted to talk to Vetterâs Carsten Press, a senior leader of the global sales organization, and business development among many operational functions.
Leading injectables (commercial dose) companies in contract marketing
Pharmaceutical Technology
SEPTEMBER 15, 2022
The surge in diseases is spurring demand for constructive treatment solutions, which is expected to boost the sales of injectable pharmaceutical companies. The document contains detailed information on the suppliers and their product offerings, alongside contact details to aid your purchasing or hiring decision.
Marketing 100
100 Leading pharmaceutical compounding companies in contract marketing
Pharmaceutical Technology
SEPTEMBER 8, 2022
. • Test method development. The information contained within the download document is intended for pharmacists, pharmaceutical executives, sales managers, manufacturers, business development managers, pharmaceutical sales representatives, and any other individual involved in the pharmaceutical compounding sector.
Marketing 100
100 Leading retail pharmacies in pharma
Pharmaceutical Technology
SEPTEMBER 7, 2022
The document contains detailed information on the suppliers and their product offerings, alongside contact details to aid your purchasing or hiring decision.
Pharmacy 113
113 
Leading commercial dose (non-sterile) companies in contract marketing
Pharmaceutical Technology
SEPTEMBER 20, 2022
The information contained within the download document is intended for pharmaceutical manufacturers, wholesalers, retailers and distributors, pharmaceutical executives, medical representatives, business development managers, retail salesmen, sales managers, pharmacy executives, and any other individual involved in pharmaceutical marketing.
Marketing 100
100 
Eli Lilly Powers Investor Confidence with New $15B Share Buyback Program
XTalks
DECEMBER 12, 2024
We will continue to focus on supporting new launches, expanding our manufacturing capacity and advancing our pipeline through research and development and business development, said Lucas Montarce, Lilly executive vice president and chief financial officer, in a press release announcing the share buyback program.
Drugs 96
96 
Automating – and optimising – HCP engagement to maximise commercial success
pharmaphorum
JANUARY 25, 2023
A data-enriched approach enables sales and marketing teams to develop targeted strategies that focus on healthcare provider (HCP) preferences while meeting budget allocations – which will be especially important in 2023 as companies try to maintain budgets in an inflationary economy.
Life Science 98
98 
Hyman, Phelps & McNamara, P.C. Names Jeff Grizzel Chief Marketing Officer
FDA Law Blog
SEPTEMBER 26, 2023
Grizzel will oversee the marketing organization, with responsibility for continuing and enhancing HP&M’s brand and expanding its business development activities. Jeff joins HP&M from Compliance Architects where he served as Vice President of Business Development.
Marketing 59
59 
Lava fires up a $700m cancer licensing deal with Seagen
pharmaphorum
SEPTEMBER 27, 2022
While a rumoured takeover by Merck & Co has yet to materialise, Seagen is getting on with its own business development, including a just-agreed licensing deal for a cancer immunotherapy developed by Dutch biotech Lava Therapeutics.
Licensing 111
111 
Leading API biologics (protein and peptide) companies in contract marketing
Pharmaceutical Technology
SEPTEMBER 14, 2022
The document contains detailed information on the suppliers and their product offerings, alongside contact details to aid your purchasing or hiring decision.
Protein 100
100 
AZ blocks former exec from taking up role at GSK – for now
pharmaphorum
SEPTEMBER 1, 2022
He was due to start at GSK this morning to lead the commercial aspects of its business development, seeking out late-stage deal opportunities as the pharma group tries to build up its pipeline and step up sales growth in the wake of its separation from consumer health business Haleon.
What we’re expecting in 2021, and beyond…
pharmaphorum
JANUARY 26, 2021
Pharma should update the role of the rep from simply delivering a sales message to more of a concierge service model, providing access to – and facilitating the delivery of – meaningful content that physicians want and need. As such, reps will need to be reskilled. Consolidation of digital health platforms.
Clinical Trials 141
141 
Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends
XTalks
AUGUST 2, 2023
Most of the company’s revenue comes from the manufacture and sale of biopharmaceutical products. They are committed to capitalizing on growth opportunities primarily through the advancement of their own product pipeline and constantly improving their existing products, as well as through business development activities.
Sales 98
98 
Let's personalize your content